| Literature DB >> 34705172 |
I M Madaeva1, O N Berdina2, E B Ukhinov2, N A Kurashova2, N V Semenova2, T A Bairova2, A V Bel'skikh2, L V Natyaganova2, S I Kolesnikov2, L I Kolesnikova2.
Abstract
Serum serotonin levels were determined by HPLC in 30 patients with diagnosed obstructive sleep apnea syndrome before and after 3-month course of PAP-therapy and in 14 subjects without obstructive sleep apnea symptoms. It was found that elimination of hypoxic conditions was associated with an increase in serotonin level. The results demonstrate the effectiveness of PAP-therapy during sleep and allow assessing the role of serotonin as a potential biomarker of intermittent hypoxia during sleep.Entities:
Keywords: apnea syndrome; biomarker; hypoxia; serotonin
Mesh:
Substances:
Year: 2021 PMID: 34705172 DOI: 10.1007/s10517-021-05301-5
Source DB: PubMed Journal: Bull Exp Biol Med ISSN: 0007-4888 Impact factor: 0.804